Enhanced osteosarcoma growth produced in rats by osteosarcoma allografts.
Transplanted syngeneic osteosarcomas (induced by 32P in DA rats) grew significantly larger in DA rats receiving a simultaneous transplant of allogeneic osteosarcoma than in rats receiving syngeneic tumour only (P less than 0-01). Two other malignant allogeneic tumours, and allogeneic spleen cells, did not alter the growth of the transplanted syngeneic osteosarcomas. When the allogeneic osteosarcoma was given 7 days before the syngeneic tumour, the reverse effect (retardation) occurred. When given 7 days after the syngeneic tumour cells, the effect on both syngeneic and allogeneic tumour growth was variable. Some possible reasons for these findings are discussed, and the argument is presented that immunological phenonema are involved in the reaction.
D000818:Animals; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009368:Neoplasm Transplantation; D012516:Osteosarcoma / Q000276:immunology / Q000473:pathology*; D051381:Rats; D012513:Sarcoma, Experimental / Q000276:immunology; D014181:Transplantation Immunology; D014184:Transplantation, Homologous; D014185:Transplantation, Isogeneic
Science. 1967 May 5;156(3775):658-9
6023661
Br Med J. 1973 Jan 20;1(5846):131-7
4513355
Pathology. 1974 Jan;6(1):71-8
4522902
Transplant Rev. 1971;7:146-78
4947773
Natl Cancer Inst Monogr. 1972 Dec;35:361-72
4512322
J Immunol. 1973 Jun;110(6):1710-2
4541309
Yale J Biol Med. 1973 Dec;46(5):693-701
4205125
Cancer Res. 1962 Sep;22:955-61
14033359
Nat New Biol. 1972 Aug 9;238(84):185-6
4340574
Int J Cancer. 1974 Apr 15;13(4):522-9
4366969